GlaxoSmithKline Launches Sale Of Two Portfolios Of Latam Consumer Health Drugs And Physiogel Skincare Drugs, Co. To Launch Sale Of A Third Portfolio Of European Health Drugs After The Summer; Aims To Raise Overall £1B From Portfolio Disposals
Benzinga Newsdesk